ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 5,070.00
-80.00 (-1.55%)
At close: Jul 21, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 103.93 billion as of July 21, 2026. Its market cap has increased by 27.06% in one year.
Market Cap
103.93B
Enterprise Value
66.64B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
5,070.00
ChartMarket Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 103.93B, a decrease of -81.48%. That is a compound annual growth rate of -29.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 103.93B | -48.00% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | 561.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 163.77B |
| Kanaph Therapeutics | 161.96B |
| Y-Biologics | 153.30B |
| Bio Solution | 152.25B |
| Prestige Biologics | 143.45B |
| ISU Abxis | 129.46B |
| TiumBio | 118.05B |
| Cell Biotech | 105.40B |